About KPV
Cell and mouse studies · Preclinical evidence
What it is studied for
The lysine-proline-valine tripeptide, studied in peptide transport and inflammatory signaling.
What selected research found
Dalmasso et al. (2008) reported reduced NF-kappaB/MAPK signaling and cytokine release in cells, plus reduced inflammation in two experimental mouse-colitis models.
Evidence limits
The study does not establish treatment of human inflammatory bowel disease, or clinical safety and efficacy of this catalog material.
Selected sources
References reviewed October 10, 2026.
Research use only. These notes summarize selected publications; they are not a systematic review, medical advice, dosing instructions, or evidence about this product lot. Clinical studies used controlled study formulations and supervision. AuraBio materials are not for human or veterinary use. Review the exact material identity and available lot documentation for your laboratory application.






Reviews
There are no reviews yet.